Chemed (CHE) | Stock Overview & Key Data
Chemed Performance Comparison
Stock Range
Today's Range
Low: $455.98
High: $465.14
on August 22, 2025
52 Week Range
Low: $408.42
High: $623.61
on August 1, 2025
on April 3, 2025
All-Time High: $654.62 on March 11, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$6.6B
EPS
19.44
P/E Ratio (TTM)
23.36
Forward P/E
18.24
P/B Ratio
5.50
PEG Ratio
-1.00
Div. Yield
0.18%
ROE
24.14%
Beta
0.460
Debt to Equity
12.15
Financial Highlights
Profitability
Gross Margin
29.85%
Operating Margin
11.00%
Profit Margin
11.56%
Returns and Earnings
Return on Assets (TTM)
13.56%
Return on Equity (TTM)
24.14%
EBITDA
$464.9M
Net Income (TTM)
$290.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$172.56
Quarterly Revenue Growth (YoY)
3.80%
Quarterly Earnings Growth (YoY)
-25.90%
Dividend Information
Last 12-Month Dividend
$1.00
Current Dividend Yield
0.18%
3-Year Average Dividend Yield
0.08%
3-Year Average Annual Dividend
$1.37
3-Year Total Dividends
$4.10
Ex-Dividend Date
November 18, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Chemed CHE | 6.62B Mid-cap | 3.13% | 1.36% | -18.24% | -16.11% | -13.05% | -19.80% | -3.27% | -10.18% |
| HCA Healthcare HCA | 94.59B Large-cap | 2.32% | 15.39% | 7.52% | 26.72% | 36.01% | 4.16% | 97.57% | 197.79% |
| Tenet Healthcare THC | 15.67B Large-cap | 4.35% | 15.09% | 11.26% | 36.44% | 43.35% | 9.10% | 198.82% | 523.05% |
| DaVita DVA | 9.84B Mid-cap | 3.68% | -3.90% | 1.33% | -1.18% | -6.31% | -8.85% | 58.33% | 61.44% |
| Ensign Group ENSG | 9.77B Mid-cap | 3.77% | 26.46% | 19.21% | 33.58% | 29.78% | 16.46% | 98.37% | 194.07% |
| Option Care Health OPCH | 4.66B Mid-cap | 1.48% | -3.49% | -10.27% | -10.41% | 26.61% | -9.71% | -9.02% | 143.77% |
Ownership & Short Interest
Insider Ownership
1.97%
Institutional Ownership
97.99%
Shares Short
384K
Short Ratio
1.93
Short % of Shares Outstanding
3.06%
Average 10-Day Volume
148K
Average 90-Day Volume
170K
Chemed Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Chemed would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CHE's 52-week high and low?
- In the last 52 weeks, Chemed reached a high of $623.61 (on April 3, 2025) and a low of $408.42 (on August 1, 2025).
- What is the market cap and P/E ratio for CHE?
- Curious about Chemed's size and valuation? Its market capitalization stands at 6.62B. When it comes to valuation, the P/E ratio (trailing twelve months) is 23.36, and the forward P/E (looking ahead) is 18.24.
- Does CHE pay dividends? If so, what's the yield?
- Yes, Chemed is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.18%, and the company has paid an average of $1.37 per share annually over the past 3 years.
- Who are Chemed's main competitors or similar companies to consider before investing?
When looking at Chemed, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA94.59B Healthcare Medical Care Facilities 4.16% 97.57% Tenet Healthcare
THC15.67B Healthcare Medical Care Facilities 9.10% 198.82% DaVita
DVA9.84B Healthcare Medical Care Facilities -8.85% 58.33% Ensign Group
ENSG9.77B Healthcare Medical Care Facilities 16.46% 98.37% Option Care Health
OPCH4.66B Healthcare Medical Care Facilities -9.71% -9.02% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Chemed Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Chemed's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 24.14%, the Debt to Equity ratio from the most recent quarter is 12.15, and its Gross Profit Margin stands at 29.85%.
- What is the recent revenue and earnings growth for CHE?
- Looking at Chemed's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.80%, and quarterly earnings saw a YoY growth of -25.90%.
- How much of CHE stock is held by insiders and institutions?
- Wondering who owns Chemed stock? Company insiders (like executives and directors) hold about 1.97% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 97.99%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.